Phospho-GATA1 (Ser142) Antibody

Code CSB-PA592144
Size US$360
Order now
Image
  • Western blot analysis of extracts from HL60 cells untreated or treated with PMA using GATA1(Phospho-Ser142) Antibody.
  • Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using GATA1(Phospho-Ser142) Antibody(left) or the same antibody preincubated with blocking peptide(right).
  • Immunofluorescence staining of methanol-fixed Hela cells using GATA1(Phospho-Ser142) Antibody.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) GATA1 Polyclonal antibody
Uniprot No.
Target Names
GATA1
Alternative Names
Anemia; X-linked; without thrombocytopenia; included antibody; ERYF 1 antibody; Eryf1 antibody; Erythroid transcription factor antibody; Erythrold transcription factor 1 antibody; GATA 1 antibody; GATA binding factor 1 antibody; GATA binding protein 1 (globin transcription factor 1) antibody; GATA binding protein 1 antibody; GATA-1 antibody; GATA-binding factor 1 antibody; GATA1 antibody; GATA1_HUMAN antibody; GF 1 antibody; GF-1 antibody; GF1 antibody; Globin transcription factor 1 antibody; NF E1 antibody; NF E1 DNA binding protein antibody; NF-E1 DNA-binding protein antibody; NFE 1 antibody; NFE1 antibody; Nuclear factor erythroid 1 antibody; Transcription factor GATA1 antibody; XLANP antibody; XLTDA antibody; XLTT antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Peptide sequence around phosphorylation site of serine 142 (R-L-S(p)-P-D) derived from Human GATA1.
Immunogen Species
Homo sapiens (Human)
Clonality
Polyclonal
Purification Method
Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
Concentration
It differs from different batches. Please contact us to confirm it.
Form
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Tested Applications
ELISA,WB,IHC,IF
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:1000
IHC 1:50-1:100
IF 1:100-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Transcriptional activator or repressor which probably serves as a general switch factor for erythroid development. It binds to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and of other genes expressed in erythroid cells. Activates the transcription of genes involved in erythroid differentiation of K562 erythroleukemia cells, including HBB, HBG1/2, ALAS2 and HMBS.
Gene References into Functions
  1. Reduced GATA-1 could be responsible for the upregulation of IRF-3 in lung adenocarcinoma cells through binding with a specific domain of IRF-3 promoter. PMID: 28566697
  2. described the functional interaction between GATA1 and SEC23B genes in two patients with suspected congenital dyserythropoietic anemia type II PMID: 28550189
  3. Here, using zebrafish, murine, and human models, the authors show that erythropoietin (EPO) signaling, together with the GATA1 transcriptional target, AKAP10, regulates heme biosynthesis during erythropoiesis at the outer mitochondrial membrane. PMID: 28553927
  4. expression of GATA1 effectively rescued maturation of Primary myelofibrosis megakaryocytes. PMID: 28240607
  5. GATA1 is an essential downstream target of SENP1 and that the differential expression and response of GATA1 and Bcl-xL are a key mechanism underlying chronic mountain sickness pathology. PMID: 27821551
  6. we herein show a long-distance regulatory region with GATA1 binding sites as being a strong enhancer for NBEAL2 expression. PMID: 28082341
  7. Single-nucleotide polymorphism in GATA1 gene is associated with non-Down syndrome transient proliferative megakaryoblastic disease. PMID: 27667142
  8. These findings indicate that erythroid specific activator GATA-1 acts at CTCF sites around the beta-globin locus to establish tissue-specific chromatin organization. PMID: 28161276
  9. Results show that GATA1 recognizes a single GATA motif or a composite of adjacent GATA motifs and exerts its diversified bindings. These binding configurations serve as one of the critical determinants of specific transcriptional regulation. PMID: 27215385
  10. Acquired and inherited GATA1 mutations contribute to Diamond-Blackfan anemia, acute megakaryoblastic leukemia, transient myeloproliferative disorder, and a group of related congenital dyserythropoietic anemias with thrombocytopenia. PMID: 28179280
  11. Our results suggest that GATAl and miR-363 were involved in the regulation of hematopoiesis via the HIF-1alpha pathway in K562 cells under hypoxic condition. PMID: 27485543
  12. analysis of GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder reveals distinctive genomic events PMID: 27353457
  13. trisomy 21 perturbed hematopoietic development through the enhanced production of early hematopoietic progenitors and the upregulation of mutated GATA1, resulting in the accelerated production of aberrantly differentiated cells. PMID: 27134169
  14. Data show that pyruvate kinase (PK) activity was decreased in the GATA1 hemizygous state and PKLR c.1284delA variant. PMID: 27342114
  15. GATA1 mutations were identified in consecutive Down syndrome patients with transient myeloproliferative disorder or acute leukemia. PMID: 26234152
  16. expression of GATA1 and SET7 was upregulated and positively correlated with VEGF expression and microvessel number in 80 breast cancer patients. GATA1 and SET7 are independent poor prognostic factors in breast cancer. PMID: 26848522
  17. Molecular cytogenetic analysis of leukemic blast cells indicated that increased blast cell status was caused by transient abnormal myelopoiesis with trisomy 21 and GATA1 mutation. PMID: 25711269
  18. deletion of P-sel disrupted megakaryocyte/neutrophil interactions in spleen, reduced TGF-beta content, and corrected the hematopoietic stem cells distribution that in Gata1(low) mice, as in primary myelofibrosis patients, is abnormally expanded in spleen. PMID: 26439305
  19. study provides insight into GATA1 transcriptional activity and may prove a useful resource for investigating the pathogenicity of noncoding variants in human erythroid disorders. PMID: 27044088
  20. The GATA-1-mediated inhibition of PU.1 gene transcription in human AML-erythroleukemias mediated through the URE represents important mechanism that contributes to PU.1 downregulation and leukemogenesis that is sensitive to DNA demethylation therapy PMID: 27010793
  21. findings provide insights into the clinically relevant in vivo function of the N-terminal domain of GATA1 in human hematopoiesis. PMID: 26713410
  22. Acute megakaryoblastic leukemia is associated with GATA-1 mutation, mimicking myeloproliferative disorders. PMID: 26205501
  23. GATA2-to-GATA1 switch is prevalent at dynamic enhancers and drives erythroid enhancer commissioning PMID: 26766440
  24. GATA1 and GATA2 are involved in clear cell renal cell carcinoma biology possibly affecting tumor development and aggressiveness. PMID: 25230694
  25. Congenital erythropoietic porphyria linked to GATA1-R216W mutation PMID: 25251786
  26. we uncovered a novel function of GATA1 in regulating Epithelial-mesenchymal transition PMID: 25726523
  27. Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression. PMID: 25682601
  28. EDAG forms complex with GATA1 and p300 and increases GATA1 acetylation and transcriptional activity by facilitating the interaction between GATA1 and p300 PMID: 24740910
  29. These results indicate that KLF1 plays a role in facilitating and/or stabilizing GATA-1 and TAL1 occupancy in the erythroid genes, contributing to the generation of active chromatin structure such as histone acetylation and chromatin looping PMID: 25528728
  30. Our case of transient leukemia without Down syndrome highlight the important role of trisomy 21 and GATA1 mutation in the development of transient neonatal leukemia. PMID: 24253371
  31. In erythroid cells, pull down experiments identified the presence of a novel complex formed by HDAC5, GATA1, EKLF and pERK which was instead undetectable in cells of the megakaryocytic lineage. PMID: 24594363
  32. Results demonstrate that expression of the hGATA1 gene is regulated through the chromatin architecture organized by 5'CTCF site-mediated intrachromosomal interactions in the hGATA1 locus. PMID: 25755285
  33. The results demonstrate that hGATA-1 and hGATA-2 expression in hippocampus is sufficient to cause depressive like behaviors. PMID: 25340772
  34. Lineage-specific GATA1 cofactor associations are essential for normal chromatin occupancy. PMID: 25621499
  35. Nkx2-5 binds to the Gata1 gene enhancer and represses the transcriptional activity of the Gata1 gene. PMID: 21464046
  36. a hypothesis is presented to explain that, in Down syndrome, the first mutational events, GATA1 somatic mutations, do not occur at random, but as a result of perturbed cell functions and specific over-expression of the GATA1 gene PMID: 24880866
  37. Data indicate that GATA1 transcription factor is downregulated in ribosomal protein S19 (RPS19)-deficient cells through upregulation of TNF-alpha and p38 MAPK. PMID: 25270909
  38. A functional link among the erythroid transcription factors GATA-1/NF-E2, miR-199b-5p in erythropoiesis. PMID: 24608802
  39. Somatic GATA1 mutations appear to be pivotal in development of transient abnormal myelopoiesis and are proving to be markers of clonal identity in its evolution to acute megakaryoblastic leukemia in subjects with Down syndrome. [CASE STUDY; REVIEW] PMID: 25268193
  40. The high rate of GATA-1 gene mutations was confirmed in newborn infants with Down's Syndrome and transient abnormal myelopoiesis or acute megakaryoblastic leukemia PMID: 24196768
  41. Results report a forth family with clinical findings consistent with an association between GATA1 gene mutation and anemia black diamond. PMID: 24766296
  42. amplitude of a transcriptional signature of GATA1 target genes was globally and specifically reduced, indicating that the activity, but not the mRNA level, of GATA1 is decreased in patients with DBA PMID: 24952648
  43. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN. PMID: 24407241
  44. High GATA1 expression is associated with hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. PMID: 24336126
  45. Mutations in the GATA1 gene associated with leukemogenesis in newborns with Down syndrome. PMID: 24222239
  46. Loss of GATA-1 full length as a cause of Diamond-Blackfan anemia phenotype. PMID: 24453067
  47. Mitochondrial translation is dramatically affected after mGatA depletion, revealing an essential role for the GatCAB enzyme in the process of protein biosynthesis in mammalian mitochondria. PMID: 24579914
  48. Our results suggest that GATA1 exon 2 mutations occur late in trisomy 21 fetal hematopoiesis PMID: 24746204
  49. A role for GATA1 in chemotherapy resistance in non-Down syndrome acute megakaryocytic leukemia cells. PMID: 23874683
  50. multiple modes of the GATA1-MED1 axis may help to fine-tune GATA1 function during GATA1-mediated homeostasis events. PMID: 24245781

Show More

Hide All

Involvement in disease
X-linked dyserythropoietic anemia and thrombocytopenia (XDAT); Thrombocytopenia with beta-thalassemia, X-linked (XLTT); Anemia without thrombocytopenia, X-linked (XLAWT)
Subcellular Location
Nucleus.
Tissue Specificity
Erythrocytes.
Database Links

HGNC: 4170

OMIM: 300367

KEGG: hsa:2623

STRING: 9606.ENSP00000365858

UniGene: Hs.765

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 322 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*